Atovaquone
NDC 31722-629, Atovaquone, suspension, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-629
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210692
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-629 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOVAQUONE750 mg/5mL
Pharmacologic classes
Antimalarial [EPC]; Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-629-21 | 31722062921 | 1 BOTTLE in 1 CARTON (31722-629-21) / 210 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2445304e-4b4e-4358-b098-31f3c49c52efNADAC price for package 31722062921
GET /v1/drugs/nadac/31722062921
Use it
Look up 31722-629 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-629 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-629. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.